• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性病的医学化和成本。

The medicalization of chronic disease and costs.

机构信息

Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, USA.

出版信息

Annu Rev Public Health. 2012 Apr;33:409-23. doi: 10.1146/annurev-publhealth-031811-124652. Epub 2012 Jan 3.

DOI:10.1146/annurev-publhealth-031811-124652
PMID:22224894
Abstract

U.S. health care spending has increased dramatically in the past several decades, consuming 17.6% percent ($2.6 trillion) of GDP in 2010. Although historical spending drivers do not account for this recent increase, two major changes in population health--the rise in obesity and obesity-related chronic disease--provide a likely explanation. This article reviews the contribution that rising treated obesity-related chronic disease prevalence and its associated treatment (spending per treated case) has made to the growth in health care spending. We discuss trends in the clinical incidence of obesity and chronic disease as well as timely advancements in disease detection, treatment, and management. Evidence shows that rising obesity rates are influencing spending largely by increasing the treated prevalence of obesity-related chronic disease. Therefore, preventing individuals from becoming treated cases in the first place is one key way that our country can cut health care spending moving forward.

摘要

在过去几十年中,美国的医疗保健支出大幅增长,2010 年占 GDP 的 17.6%(2.6 万亿美元)。尽管历史支出驱动因素不能解释最近的这种增长,但人口健康的两个重大变化——肥胖率的上升和与肥胖相关的慢性疾病——提供了一个可能的解释。本文回顾了治疗肥胖相关慢性疾病的患病率上升及其相关治疗(每个治疗病例的支出)对医疗保健支出增长的贡献。我们讨论了肥胖和慢性疾病的临床发病率的趋势,以及疾病检测、治疗和管理方面的及时进展。有证据表明,肥胖率的上升主要是通过增加与肥胖相关的慢性疾病的治疗患病率来影响支出。因此,防止人们首先成为治疗病例是我国今后降低医疗保健支出的一个关键途径。

相似文献

1
The medicalization of chronic disease and costs.慢性病的医学化和成本。
Annu Rev Public Health. 2012 Apr;33:409-23. doi: 10.1146/annurev-publhealth-031811-124652. Epub 2012 Jan 3.
2
The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011.慢性病、肥胖以及治疗与检测水平的提高在解释1987年至2011年医疗支出增长方面所起的作用。
Appl Health Econ Health Policy. 2015 Aug;13(4):381-7. doi: 10.1007/s40258-015-0164-7.
3
Treated disease prevalence and spending per treated case drove most of the growth in health care spending in 1987-2009.在 1987 年至 2009 年期间,医疗保健支出的增长主要归因于治疗疾病的患病率和每个治疗病例的支出。
Health Aff (Millwood). 2013 May;32(5):851-8. doi: 10.1377/hlthaff.2012.0391.
4
Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity.美国医疗保健支出增长的影响因素:疾病患病率上升和治疗强度的作用。
Public Health. 2006 Nov;120(11):1002-7. doi: 10.1016/j.puhe.2006.09.001. Epub 2006 Oct 9.
5
Rising rates of chronic health conditions: what can be done?慢性健康状况发病率上升:我们能做些什么?
Issue Brief Cent Stud Health Syst Change. 2008 Nov(125):1-4.
6
The impact of obesity on rising medical spending.肥胖对医疗支出上升的影响。
Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-480-6. doi: 10.1377/hlthaff.w4.480.
7
The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011.肥胖与慢性病对医疗保险支出的影响,1987 - 2011年
Pharmacoeconomics. 2015 Jul;33(7):691-7. doi: 10.1007/s40273-015-0284-9.
8
Chronic conditions account for rise in Medicare spending from 1987 to 2006.慢性疾病导致 1987 年至 2006 年期间医疗保险支出的增长。
Health Aff (Millwood). 2010 Apr;29(4):718-24. doi: 10.1377/hlthaff.2009.0474. Epub 2010 Feb 18.
9
Health spending in OECD countries in 2004: an update.经合组织国家2004年的卫生支出:最新情况
Health Aff (Millwood). 2007 Sep-Oct;26(5):1481-9. doi: 10.1377/hlthaff.26.5.1481.
10
The effects of obesity, smoking, and drinking on medical problems and costs.肥胖、吸烟和饮酒对医疗问题及费用的影响。
Health Aff (Millwood). 2002 Mar-Apr;21(2):245-53. doi: 10.1377/hlthaff.21.2.245.

引用本文的文献

1
Trends in chronic disease incidence rates from the Canadian Chronic Disease Surveillance System.加拿大慢性病监测系统中慢性病发病率趋势。
Health Promot Chronic Dis Prev Can. 2019 Jun;39(6-7):216-224. doi: 10.24095/hpcdp.39.6/7.02.
2
Noradrenaline transporter availability on [C]MRB PET predicts weight loss success in highly obese adults.[C]MRB PET 示踪剂检测去甲肾上腺素转运体可预测重度肥胖成年人的减肥成功。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1618-1625. doi: 10.1007/s00259-018-4002-7. Epub 2018 Apr 7.
3
Future directions of multiple behavior change research.
多行为改变研究的未来方向。
J Behav Med. 2017 Feb;40(1):194-202. doi: 10.1007/s10865-016-9809-8. Epub 2016 Oct 26.
4
Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.社区药剂师在艾滋病毒感染者护理中是否未得到充分利用?需要进行结构和政策变革。
J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):19-30. doi: 10.1331/JAPhA.2015.14107.
5
Implementing community-based diabetes programs: the scripps whittier diabetes institute experience.实施社区为基础的糖尿病项目:斯克里普斯惠蒂尔糖尿病研究所的经验。
Curr Diab Rep. 2014 Feb;14(2):462. doi: 10.1007/s11892-013-0462-0.
6
Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.肥胖患者去甲肾上腺素转运体的可利用性降低:用 [(S,S)-[(11)C]O-甲基麦角环肽行正电子发射断层显像。
Neuroimage. 2014 Feb 1;86:306-10. doi: 10.1016/j.neuroimage.2013.10.004. Epub 2013 Oct 10.
7
High-intensity emergency department visits increased in California, 2002-09.加利福尼亚州 2002-2009 年高强度急诊科就诊量增加。
Health Aff (Millwood). 2013 Oct;32(10):1811-9. doi: 10.1377/hlthaff.2013.0397.
8
Phentermine and topiramate for the management of obesity: a review.用于肥胖症管理的芬特明和托吡酯:综述
Drug Des Devel Ther. 2011 Apr 5;7:267-78. doi: 10.2147/DDDT.S31443. Print 2013.
9
Insurance coverage for weight loss: overweight adults' views.减肥保险覆盖范围:超重成年人的观点。
Am J Prev Med. 2013 May;44(5):453-8. doi: 10.1016/j.amepre.2013.01.021.
10
Does well-child care have a future in pediatrics?儿童保健在儿科学中有未来吗?
Pediatrics. 2013 Apr;131 Suppl 2(Suppl 2):S149-59. doi: 10.1542/peds.2013-0252f.